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Summary 
Background. Multidrug-resistant (MDR) Gram negative rods
are increasingly being reported in sub-Saharan Africa. Molecular
investigations play an important role, alongside other measures, in
controlling nosocomial infections attributed to these organisms.
This study aimed to determine the common extended spectrum
beta-lactamases (ESBL) and carbapenemases genes, and clonal
relationship in MDR Klebsiella pneumoniae and Escherichia coli.
Methods. Fifty-four MDR isolates collected at the Aga Khan
University hospital, Nairobi in the month of August 2012 formed
the study. These were picked after an increase in the number of
resistant strains during the said period was experienced. 
Results. blaCTXM was present in 41 (74%) of the isolates,
while blaSHV was detected in 18 (33%) and blaTEM in 13 (24%) of
the isolates. 
Nine (16.7%) of the isolates harboured all three ESBL genes
and 8 (14.8%) harboured two. Eight of the isolates (all E. coli) had
none of the ESBL genes tested. Two isolates harboured carbapen-
emases genotypes: one had blaNDM-1 and the other blaSPM.
Sequencing matched CTXM-15 and TEM-1 genes in all the
isolates harbouring blaCTXM and blaTEM respectively. However,
there was diversity in blaSHV with SHV-11 and SHV-12 genes pre-
dominant. The isolates were non-clonal.
Conclusions. The isolates mostly harboured blaCTX-M-15 while
only a few had carbapenemases genes. Lack of clonality suggests
these were the stable circulating strains at the time of the study.
Introduction
The prevalence of antimicrobial resistance varies greatly
between and within countries for different pathogens. Infections
with multidrug-resistant (MDR) organisms have been linked with
poorer clinical outcomes and prolonged hospitalization on average
compared to infections with susceptible pathogens. This is likely
exacerbated in resource-limited settings, where access to newer
(usually more expensive) antibiotics is often limited by cost (27).
The factors that contribute to the emergence and spread of
MDR microorganisms in developing countries are varied. These
factors include inappropriate antimicrobial use by both medical
personnel and the public, which is due to lack of prescribing skills
or lack of access to microbiology laboratory reports (by the med-
ical personnel), or due to unregulated access of patients to antibi-
otics in the retail market (28). Infection control practices within
hospitals are in most places makeshift and often health care per-
sonnel may be unaware of emerging or existing multiresistant
microorganisms due to lack of surveillance data coupled with
inadequate microbiology laboratory facilities (15). 
Extended spectrum beta-lactams and carbapenems are among
the popular antimicrobials prescribed in severe infections.
Therefore, antimicrobial resistance to these agents is of clinical
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and public health importance. ESBLs are beta lactamases capable
of conferring bacterial resistance to the penicillins as well as first-
, second (but not the cephamycins) -, and third-generation
cephalosporins, and aztreonam. On the other hand, carbapene-
mases are carbapenem-hydrolyzing beta-lactamases that confer
resistance to a broad spectrum of beta-lactam substrates, including
carbapenems. Recent studies performed in the region of East
Africa show a wide variation in ESBLs prevalence in hospitals
between the different countries with a pooled proportion of 40%
reported in a meta-analysis (23). Carbapenemases have been doc-
umented in several countries in Africa and Rendani et al. in their
systematic review have suggested that the problem might be bigger
than what is currently estimated due to underreporting (11). 
Molecular studies can be helpful in understanding the epidemi-
ology of evolving and established MDR isolates in hospitals.
Application of molecular techniques in infection control is gaining
worldwide acceptance as the costs of carrying out the tests
decrease; an example being whole genome sequencing which was
employed to track an outbreak of a carbapenemase producing
Klebsiella pneumoniae at a hospital in the USA (22). The Aga
Khan University Hospital Nairobi (AKUHN) is a 250 bed tertiary
and teaching hospital that caters mainly to the middle income pop-
ulation within the city, but also processes samples from across the
country referred through its various outreach medical centres. The
hospital runs an accredited microbiology laboratory.
Multidrug-resistant Enterobacteriaceae are often isolated in
clinical specimens from both inpatients and outpatients at
AKUHN. They are frequently implicated in infections involving
the bloodstream, urinary tract, abdomen, skin and soft tissue.
According to data on bloodstream infections (BSI) in the hospital
from 2012 to 2014 only 30% of Klebsiella pneumoniae and 51%
of Escherichia coli were susceptible to 3rd generation
cephalosporins, while 59% and 41%, were susceptible to fluoro-
quinolones respectively (3).
Although some of the studies on antibiotic resistance in Gram
negative rods conducted at this hospital have involved molecular
techniques, few have addressed the issue of clonality among iso-
lates within and between different locations in the hospital.
In the weeks leading to the month of August 2012 we noticed
an increase in the number of MDR K. pneumoniae and E. coli and
sought to determine the molecular mechanisms of resistance and
clonality in these isolates at AKUHN.
Materials and Methods
In the month of August 2012 a total of 143 E. coli and 38 K.
pneumoniae isolates were cultured from clinical specimens in the
microbiology laboratory. Among these, 35 (24%) were MDR E.
coli, and 19 (50%) MDR K. pneumoniae respectively. The patients
who provided the samples ranged from less than a month to 90
years in age with a median of 38. There were more females (35)
than males (19), which was attributed to a preponderance of UTIs
in the females. Thirty of the isolates were from outpatients and 24
from inpatients. Multidrug-resistance was defined as non-suscepti-
bility to one or more agents in three or more of the following
antimicrobial agents: aminoglycosides, carbapenems,
cephalosporins, fluoroquinolones, monobactams and penicillins. 
Identification and susceptibility testing were performed using
GNR and GN126 cards respectively on Vitek2 system (VITEK® 2
bioMérieux, France). The Advanced Expert System (AES) on
Vitek2 configured the most likely phenotype for the majority of the
isolates as extended spectrum beta-lactamase (ESBL). The Clinical
Laboratory and Standard Institutes (CLSI) guidelines for suscepti-
bility breakpoints (version 2009) were used in this study. 
DNA extraction
Fresh colonies were used for total bacterial DNA extraction
using the ZR fungal/Bacterial DNA MiniPrep kit (Zymo Research
Corp. USA) according to the manufacturer’s protocol, with a final
elution volume of 50 uL.
PCR 
PCR for the common ESBL and carbapenemases genotypes
blaCTX-M; blaSHV; blaTEM; blaKPC, blaSPM; blaGES; blaIMP; blaNDM;
blaOXA; and blaVIM was performed using generic primers sourced
from the University of Cape Town Oligonucleotide Synthesis
Service (Table 1). Only isolates reported as non-susceptible to
meropenem (MIC ≥4 ug/mL) were tested for the presence of car-
bapenemase genes. For each target gene, PCR amplification was
carried out in a 50 μL reaction volume containing 1.25 units Taq
DNA polymerase, 1.5 mM MgCl, 0.2 μM of each of the forward
and reverse primers, 200 μM of each dNTP, 12.5 μL of PCR water,
and 2.5 μL of DNA template.
The PCR amplicons were subjected to gel electrophoresis on PS
500X (Hoefer Scientific instruments, USA) at 80 V for one hour, and
then visualized using the Chemie Genius2Bio imaging system
(Syngene, UK) after staining the gel with ethidium bromide.
Sequencing
The amplicons were sequenced using ABI3730xl (Life
Technologies, USA) and the sequences assembled using the
DNABaser software (Heracle BioSoft S.R.L, Romania).
Sequences were compared to the published GenBank sequences
using BLAST.
Pulsed field gel electrophoresis (PFGE)
PFGE was performed according to the PulseNet protocol for E.
coli (www.cdc.gov/pulsenet/pdf/ecoli-shigella-pfge-protocol-
508.pdf) with modification-the restriction digestion time was
extended to 3 hours at 37°C. Only16 of the E. coli and 15 K. pneu-
moniae isolates were successfully typed.
The PFGE images were viewed in the Chemie Genius Bio
imaging system (Syngene, UK) and analyzed using GelCompar
software (Applied Maths, Belgium). Pulsotypes were derived by
visualizing the bands and by computation based on the level of
relatedness according to the DICE similarity coefficient and
UPMGA. Optimization and tolerance limits were set at 1%. 
Isolates displaying ≥94% similarity (≈3 band difference) were
assigned the same pulsotypes (26).
Results
The majority (70%) of isolates were obtained from outpatient
urine samples (Table 2). Other locations included the wards and
critical care units that provided a variety of specimens. E. coli was
mainly isolated in UTIs in outpatients while K. pneumoniae was
associated with a variety of infections in inpatients.
The isolates were resistant to the majority of the 18 antibiotics
tested against with the exception of meropenem and amikacin
(Figure 1).
PCR for the ESBL genes showed that overall blaCTXM was present
in 41 (74%) of the isolates, blaSHV in 18 (33%) and blaTEM in13 (24%)
(Table 2). There were notable differences between the two bacteria
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species in the proportion of isolates harbouring SHV; E. coli none, K.
pneumoniae 18 (94.7%), and TEM; E.coli 3 (8.6%) and K. pneumo-
niae 10 (52.6%). Sequence analysis showed that all CTX-M genes
were blaCTX-M-15 and all TEM-related genes were blaTEM-1. The pre-
dominant SHV-related genes were blaSHV-11, 10 (55.6%) and blaSHV-12
6 (33.3%). Others were blaSHV-2 and blaSHV-1 each present in a single
isolate. blaSHV was exclusively found in K. pneumoniae while blaCTXM
and blaTEM were present in both of the microorganisms.
Nine (16.7%) of the isolates harboured all three ESBL genes
and 8 of the isolates (14.8%) harboured two. Eight of the isolates
(all E. coli) harboured none of the genes tested; all 8 of these iso-
lates showed phenotypic resistance to 3rd generation
cephalosporins.
Only two isolates harboured carbapenemases genes: one had
blaNDM-1 and the other blaSPM; both were Klebsiella pneumoniae.
Molecular typing was performed in 16 of E. coli and 15 of K.
pneumoniae isolates. Only two E. coli isolates (E4 and E20)
belonged to the same pulsotype, while all of the K. pneumoniae
isolates belonged to separate pulsotypes (Figures 2 and 3).
                                Article
Table 1. Primers used for detection of resistance genes.
Primer                                 Primer sequence (5’-3’)                   Annealing temperature          Amplicon size (bp)              Reference
SHV                F                        CGC CGG GTT ATT CTT ATT TGT CGC                                     68°C                                                   1016                                           (14)
                       R                       TCT TTC CGA TGC CGC CGC CAG TCA
TEM              F                            CTT CCT GTT TTT GCT CAC CCA                                          58°C                                                    717                                             (3)
                       R                             TAC GAT ACG GGA GGG CTT AC
CTX-M          F                         TTT GCG ATG TGC AGT ACC AGT AA                                       51°C                                                    544                                             (6)
                       R                          CGA TAT CGT TGG TGG TGC CAT A
KPC               F                                CGTCTAGTTCTGCTGTCTTG                                              55°C                                                    798                                            (19)
                       R                                CTTGTCATCCTTGTTAGGCG
SPM               F                                 CCTACAATCTAACGGCGACC                                              55°C                                                    650                                            (19)
                       R                                TCGCCGTGTCCAGGTATAAC
GES               F                                  CTATTACTGGCAGGGATCG                                               55°C                                                    594                                            (19)
                       R                                   CCTCTCAATGGTGTGGGT
NDM             F                                GGTTTGGCGATCTGGTTTTC                                              55°C                                                    621                                            (19)
                       R                                CGGAATGGCTCATCACGATC
VIM               F                                  GATGGTGTTTGGTCGCATA                                               55°C                                                    390                                            (19)
                       R                                    CGAATGCGCAGCACCAG
OXA-48         F                                GCGTGGTTAAGGATGAACAC                                              55°C                                                    438                                            (19)
                       R                                 CATCAAGTTCAACCCAACCG
IMP               F                                 GGAATAGAGTGGCTTAAYTC                                               55°C                                                    232                                            (19)
                       R                               TCGGTTTAAYAAAACAACCACC
Table 2. Specimen type and resistance genes among the isolates. 
                                                                               E. coli                                                       K. pneumoniae
                                                                              (n=35)                                                            (n=19)
Specimen type: n (%)
Urine                                                                                        28 (80.0)                                                                             10 (52.6)
Respiratory                                                                                 0 (0)                                                                                 3 (15.8)
Pus / swabs                                                                               3 (8.6)                                                                                2 (10.5)
Blood Culture                                                                           3 (8.6)                                                                                2 (10.5)
Other                                                                                          1 (2.9)                                                                                2 (10.5)
Beta lactamase: n (%)
bla-CTX-M                                                                               26 (74.3)                                                                             15 (78.9)
bla-TEM                                                                                     3 (8.6)                                                                               10 (52.6)
bla-SHV                                                                                        0 (0)                                                                                18 (94.7)
Figure 1. Proportion of isolates resistant to specific antibiotics
(n=54). AMK amikacin; AMP ampicillin; AUG amoxil/clavu-
lanate; CAZ ceftazidime; CIP ciprofloxacin; CPD cefpodoxime;
CTX cefotaxime; CXM cefuroxime; FAL cefalotin; FEP cefepime;
FOX cefoxitin; GEN gentamicin; MERO meropenem; NOR nor-













We analyzed the molecular characteristics of multidrug resistant
K. pneumoniae and E. coli isolates collected during one month at
AKUHN to determine the common ESBL and carbapenemase
genes, as well as to describe the clonal relationship of the isolates.
The predominant genotype was blaCTX-M-15 and was harboured by 41
(74%) isolates. This finding was similar to that of an earlier study
carried out in the hospital involving community acquired infections
caused by the two organisms (10). The multidrug resistant isolates
were present in all locations sampled in the hospital. Not surprising-
ly the majority of these isolates were implicated in urinary tract
infections in the outpatient department. blaCTX-M-15 has a worldwide
presence and is one of the most common variants detected in clini-
cally important pathogens, and predominates in most of Europe,
North America, the Middle East and India (8, 29). Data from Africa
seem to suggest it is also prevalent in this continent. A study in the
neighboring Tanzania on ESBL producing K. pneumoniae found that
among 92 isolates, 68 (74%) had blaCTX-M-15 (13).
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Figure 2. PFGE E. coli. HDU- high dependence unit; ICU- intensive care unit.
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Presence of the genotype blaCTX-M-15 has also been reported in
other countries including Morocco, Tunisia, Algeria, Egypt,
Nigeria and South Africa (16, 25). Apart from humans the environ-
ment as well as animals that are a food source serve as reservoirs
for ESBLs and studies done on different continents have docu-
mented evidence, which in part explains the global presence and
spread of ESBLs (1, 2, 12). 
Eight of the isolates with phenotypic resistance to 3rd genera-
tion cephalosporins did not harbour any of the common ESBL
genes tested. It is possible that other mechanisms of resistance,
besides beta-lactamases, or other beta-lactamases whose genes
were not tested for could be involved. One possible mechanism is
the presence of AmpC beta-lactamases; however this seems
unlikely considering that among the eight isolates only one was
resistant to cefoxitin. Another plausible explanation is the presence
of false positive ESBL phenotypes as determined by the automated
system (Vitek2) since it is not 100% specific for ESBLs.
Specificity varies between studies with some reporting above 97%
(21, 24) while others report values lower than 90% (4, 7). In our
study, confirmatory tests for ESBL production for the eight isolates
were not were not performed.
Only 2 isolates, both Klebsiella, were found to harbour car-
bapenemases genes i.e. blaNDM-1 and blaSPM.
blaNDM-1 which gained prominence in the last decade had been
described in K. pneumoniae isolates dating back to 2007 in this
hospital and later was also isolated in Acinetobacter baumanii
(18, 20). However, carbapenemases producing K. pneumoniae
and E. coli have remained relatively uncommon compared to
ESBLs in Kenya. A systematic review that analysed carbapene-
mase-producing bacteria in Africa found diverse prevalence
among hospital isolates ranging from to 2.3% to 67.7%. The
review concluded that antibiotic stewardship and surveillance
systems, including molecular typing of resistant isolates, should
be implemented to control the spread of carbapenemase-produc-
ing bacteria (11).
The SPM- type carbapenemase is a metallo-beta-lactamase
(MBL) that is reported mostly in South America among
Pseudomonas aeruginosa (P. aeruginosa) and Acinetobacter bau-
manii (A. baumanii). There are limited data on the prevalence of
the SPM-type carbapenemase in Africa. A study conducted in
Uganda showed that 16 % (4/25) of carbapenem-resistant P. aerug-
inosa harboured blaSPM (5).
Although only a limited number of isolates were analysed by
PFGE, results show the existence of different pulsotypes among
the two species within the various hospital locations and makes
clonal spread of the MDR isolates less likely. However, these
studies need to be repeated to involve larger numbers of isolates
collected over a longer time span to better understand the emer-
gence and spread of the resistant isolates. Molecular investiga-
tions integrated with conventional hospital epidemiologic sur-
veillance can be cost effective in reducing nosocomial infections
(17). Clonality can be used to track the source and spread of an
infection and a relapse from a re-infection. These information
can lead to targeted infection control measures. However, the
resources required to perform molecular studies are prohibitive
in under-resourced countries- a situation that prevails in most of
Africa. 
The research reported here had limitations including low num-
ber of isolates typed and limited time of the study. However, we
believe it provides a snapshot of what was happening in the hospi-
tal at the time, and can be used to assist future studies. Most impor-
tantly, it suggests that clonal dissemination of these resistant iso-
lates is unlikely.
Conclusions
MDR E. coli and K. pneumoniae mostly harboured blaCTX-M-15,
and carbapenemases were uncommon. Among the isolates that
underwent molecular typing no clonality was demonstrated sug-
gesting they arose by means other than clonal spread, and were
probably the stable circulating strains at the time of the study.
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